|
1.
|
|
9 p, 1.1 MB |
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis
/
Díaz, Luis Antonio (Pontificia Universidad Católica de Chile) ;
Fuentes-López, Eduardo (Pontificia Universidad Católica de Chile) ;
Ayares, Gustavo (Pontificia Universidad Católica de Chile) ;
Idalsoaga, Francisco (Pontificia Universidad Católica de Chile) ;
Arnold, Jorge (Pontificia Universidad Católica de Chile) ;
Valverde, María Ayala (Hospital El Pino) ;
Perez, Diego (Hospital El Pino) ;
Gómez, Jaime (Hospital El Pino) ;
Escarate, Rodrigo (Hospital El Pino) ;
Villalón, Alejandro (Universidad de Antofagasta) ;
Ramírez, Carolina A. (Western University) ;
Hernandez-Tejero, Maria (Hospital Clínic i Provincial de Barcelona) ;
Zhang, Wei (Massachusetts General Hospital) ;
Qian, Steve (University of Florida) ;
Simonetto, Douglas A. (Mayo Clinic) ;
Ahn, Joseph C. (Mayo Clinic) ;
Buryska, Seth (Mayo Clinic) ;
Dunn, Winston (University of Kansas Medical Center) ;
Mehta, Heer (University of Kansas Medical Center) ;
Agrawal, Rohit (University of Illinois) ;
Cabezas, Joaquín (Instituto de Investigación Valdecilla (IDIVAL)) ;
García-Carrera, Inés (Instituto de Investigación Valdecilla (IDIVAL)) ;
Cuyàs, Berta (Institut d'Investigació Biomèdica Sant Pau) ;
Poca Sans, Maria (Institut d'Investigació Biomèdica Sant Pau) ;
Soriano, German (Institut d'Investigació Biomèdica Sant Pau) ;
Sarin, Shiv K. (Institute of Liver and Biliary Sciences) ;
Maiwall, Rakhi (Institute of Liver and Biliary Sciences) ;
Jalal, Prasun K. (Baylor College of Medicine) ;
Abdulsada, Saba (Baylor College of Medicine) ;
Higuera-de-la-Tijera, Fátima (Universidad Nacional Autónoma de México) ;
Kulkarni, Anand V. (Asian Institute of Gastroenterology) ;
Rao, P. Nagaraja (Asian Institute of Gastroenterology) ;
Salazar, Patricia Guerra (Instituto de Gastroenterología Boliviano-Japonés) ;
Skladaný, Lubomir (Slovak Medical University) ;
Bystrianska, Natália (Slovak Medical University) ;
Clemente-Sanchez, Ana (CIBERehd Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Madrid) ;
Villaseca-Gómez, Clara (CIBERehd Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Madrid) ;
Haider, Tehseen (Montefiore Medical Center) ;
Chacko, Kristina R. (Montefiore Medical Center) ;
Romero, Gustavo A. (Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo) ;
Pollarsky, Florencia D. (Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo) ;
Restrepo, Juan Carlos (Unidad de Hepatología del Hospital Pablo Tobon Uribe) ;
Castro-Sanchez, Susana (Grupo de Gastrohepatología de la Universidad de Antioquia) ;
Toro, Luis G. (Hospitales de San Vicente Fundación de Medellín y Rionegro) ;
Yaquich, Pamela (Hospital San Juan de Dios) ;
Mendizabal, Manuel (Hospital Universitario Austral) ;
Garrido, Maria Laura (Hospital Central Dr. Ramon Carrillo) ;
Marciano, Sebastián (Hospital Italiano de Buenos Aires) ;
Dirchwolf, Melisa (Hospital Privado de Rosario) ;
Vargas Blasco, Víctor Manuel (Hospital Universitari Vall d'Hebron) ;
Jiménez, César (Hospital Universitari Vall d'Hebron) ;
Louvet, Alexandre (Hôpital Claude Huriez) ;
García-Tsao, Guadalupe (Yale University School of Medicine/VA-CT Healthcare System) ;
Roblero, Juan Pablo (Hospital Clínico Universidad de Chile) ;
Abraldes, Juan G. (University of Alberta) ;
Shah, Vijay H. (Mayo Clinic) ;
Kamath, Patrick S. (Mayo Clinic) ;
Arrese, Marco (Pontificia Universidad Católica de Chile) ;
Singal, Ashwani K. (Avera Transplant Institute) ;
Bataller, Ramon (Hospital Clínic i Provincial de Barcelona) ;
Arab, Juan Pablo (Western University) ;
Universitat Autònoma de Barcelona
Model for End-Stage Liver Disease (MELD) score better predicts mortality in alcohol-associated hepatitis (AH) but could underestimate severity in women and malnourished patients. Using a global cohort, we assessed the ability of the MELD 3. [...]
2023 -  10.1016/j.jhepr.2023.100727
JHEP Reports, Vol. 5 (march 2023)
|
|
|
2.
|
|
10 p, 673.5 KB |
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors : A Retrospective, Multinational, Multicentre Study
/
Torres, Tiago (University of Porto, Portugal) ;
Chiricozzi, Andrea (Università Cattolica del Sacro Cuore, Rome, Italy) ;
Puig Sanz, Lluís (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Lé, Ana Maria (Centro Académico Clínico ICBAS - CHP, Porto, Portugal) ;
Marzano, Angelo Valerio (Università degli Studi di Milano, Italy) ;
Dapavo, Paolo (University of Turin, Italy) ;
Dauden, Esteban (Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid) ;
Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Lazaridou, Elizabeth (Aristotle University School of Medicine, Thessaloniki, Greece) ;
Duarte, Gleison (Instituto Bahiano de Imunoterapias-IBIS, Salvador, Brazil) ;
Carvalho, André V. E. (Hospital Moinhos de Vento, Porto Alegre, Brazil) ;
Romiti, Ricardo (University of São Paulo, Brazil) ;
Rompoti, Natalia (University of Athens, 'A. Sygros' Hospital for Skin and Venereal Diseases, Athens, Greece) ;
Teixeira, Laetitia (Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Portugal) ;
Abreu, Miguel (University of Porto, Portugal) ;
Ippoliti, Elena (Università Cattolica del Sacro Cuore, Rome, Italy) ;
Maronese, Carlo Alberto (Università degli Studi di Milano, Italy) ;
Llamas-Velasco, Mar (Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP)) ;
Vilarrasa-Rull, Eva (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
del Alcázar, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Daponte, Athina-Ioanna (Aristotle University School of Medicine, Thessaloniki, Greece) ;
Papoutsaki, Marina (University of Athens, 'A. Sygros' Hospital for Skin and Venereal Diseases, Athens, Greece) ;
Carugno, Andrea (ASST Papa Giovanni XXIII, Bergamo, Italy) ;
Bellinato, Francesco (University Hospital of Verona, Italy) ;
Gisondi, Paolo (University Hospital of Verona, Italy) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Tuberculosis has a major global impact. Immunocompetent hosts usually control this disease, resulting in an asymptomatic latent tuberculosis infection (LTBI). Because TNF inhibitors increase the risk of tuberculosis reactivation, current guidelines recommend tuberculosis screening before starting any biologic drug, and chemoprophylaxis if LTBI is diagnosed. [...]
2024 - 10.1007/s40257-024-00845-4
American Journal of Clinical Dermatology, Vol. 25, Num. 2 (march 2024) , p. 333-342
|
|
|
3.
|
|
17 p, 4.9 MB |
Effects of Varicocele Repair on Sperm DNA Fragmentation and Seminal Malondialdehyde Levels in Infertile Men with Clinical Varicocele : A Systematic Review and Meta-Analysis
/
Cannarella, Rossella (Global Andrology Forum, Moreland Hills, OH) ;
Shah, Rupin (Lilavati Hospital) ;
Saleh, Ramadan (Sohag University) ;
Boitrelle, Florence (Paris Saclay University) ;
Hamoda, Taha Abo-Almagd Abdel-Meguid (Minia University) ;
Singh, Rajender (Central Drug Research Institute (Lucknow)) ;
Salvio, Gianmaria (Polytechnic University of Marche) ;
Toprak, Tuncay (University of Health Sciences (Istanbul)) ;
Falcone, Marco (University of Turin) ;
Gül, Murat (Selçuk University School of Medicine) ;
Dimitriadis, Fotios (Aristotle University of Thessaloniki) ;
Rambhatla, Amarnath (Vattikuti Urology Institute) ;
Russo, Giorgio Ivan (University of Catania) ;
Ko, Edmund (Loma Linda University Health) ;
Zini, Armand (McGill University) ;
Kavoussi, Parviz (Austin Fertility & Reproductive Medicine/Westlake IVF) ;
Phuoc, Nguyen Ho Vinh (Pham Ngoc Thach University of Medicine) ;
Kandil, Hussein (Fakih IVF Fertility Center) ;
Ghayda, Ramy Abou (Case Western Reserve University) ;
Birowo, Ponco (Universitas Indonesia) ;
Gherabi, Nazim (Algiers University) ;
Ceyhan, Erman (Baskent University) ;
Dong, Jie (The Fourth Military Medical University) ;
Malhotra, Vineet (SCM Clinic and Hospital (New Delhi)) ;
Durairajanayagam, Damayanthi (Universiti Teknologi MARA) ;
Kolbasi, Bircan (Istanbul Medipol University) ;
Bahar, Fahmi (Siloam Sriwijaya Hospital) ;
Calik, Gokhan (Istanbul Medipol University) ;
Çayan, Selahittin (University of Mersin School of Medicine) ;
Pinggera, Germar-Michael (Medical University Innsbruck) ;
Calogero, Aldo E. (Global Andrology Forum) ;
Rajmil, Osvaldo (Institut de Recerca Sant Pau) ;
Mostafa, Taymour (Cairo University) ;
Atmoko, Widi (Universitas Indonesia) ;
Harraz, Ahmed M. (Mansoura University) ;
Le, Tan V. (Pham Ngoc Thach University of Medicine) ;
de la Rosette, Jean (Istanbul Medipol Mega University Hospital) ;
Hakim, Lukman (Universitas Airlangga) ;
Pescatori, Edoardo (Next Fertility GynePro) ;
Sergeyev, Oleg (Research Centre for Medical Genetics (Moscou)) ;
Rashed, Ayman (6th October University) ;
Saini, Pallavi (Central Drug Research Institute (Lucknow)) ;
Agarwal, Ashok (Cleveland Clinic) ;
Universitat Autònoma de Barcelona
Varicoceles can be a source of elevated seminal oxidative stress (OS) and sperm DNA fragmentation (SDF). However, it remains unclear whether varicocele repair (VR) could reduce these parameters. This systematic review and meta-analysis (SRMA) aims to investigate the impact of VR on SDF and seminal malondialdehyde (MDA). [...]
2024 - 10.5534/wjmh.230235
The world journal of men's health, Vol. 42 (january 2024) , p. 321-337
|
|
|
4.
|
|
26 p, 2.2 MB |
Inherited human ezrin deficiency impairs adaptive immunity
/
García-Solís, Blanca (Hospital Universitario La Paz (Madrid)) ;
Van Den Rym, Ana (Hospital Universitario La Paz (Madrid)) ;
Martinez-Martinez, Laura (Institut d'Investigació Biomèdica Sant Pau) ;
Franco-Leyva, Teresa (Institut d'Investigació Biomèdica Sant Pau) ;
Pérez-Caraballo, Jareb J. (Vanderbilt University Medical Center) ;
Markle, Janet (Vanderbilt University Medical Center) ;
Cubillos-Zapata, Carolina (Centre for Biomedical Research Network) ;
Marín, Ana V. (Centro de investigación Hospital Universitario 12 de Octubre) ;
Recio, María J. (Centro de investigación Hospital Universitario 12 de Octubre) ;
Regueiro, José R. (Centro de investigación Hospital Universitario 12 de Octubre) ;
Navarro-Zapata, Alfonso (Hospital Universitario La Paz (Madrid)) ;
Mestre-Durín, Carmen (Hospital Universitario La Paz (Madrid)) ;
Ferreras, Cristina (Hospital Universitario La Paz (Madrid)) ;
Cotázar, Carla Martín (Hospital Universitario La Paz (Madrid)) ;
Mena, Roció (Hospital Universitario La Paz (Madrid)) ;
de la Calle-Fabregat, Carlos (Institut d'Investigació contra la Leucèmia Josep Carreras) ;
López-Lera, Alberto (Hospital Universitario La Paz (Madrid)) ;
Arquero, Miguel Fernández (Hospital Clínico San Carlos (Madrid)) ;
Pérez-Martínez, Antonio (Hospital Universitario La Paz (Madrid)) ;
López-Collazo, Eduardo (Hospital Universitario La Paz (Madrid)) ;
Sánchez-Ramón, Silvia (Hospital Clínico San Carlos (Madrid)) ;
Casanova, Jean-Laurent (Howard Hughes Medical Institute) ;
Martínez-Barricarte, Rubén (Vanderbilt University Medical Center) ;
de la Calle-Martín, Oscar (Institut d'Investigació Biomèdica Sant Pau) ;
de Diego, Rebeca Pérez (Hospital Universitario La Paz (Madrid)) ;
Universitat Autònoma de Barcelona
Inborn errors of immunity (IEI) are a group of monogenic diseases that confer susceptibility to infection, autoimmunity, and cancer. Despite the life-threatening consequences of some IEI, their genetic cause remains unknown in many patients. [...]
2023 - 10.1016/j.jaci.2023.05.022
The Journal of Allergy and Clinical Immunology, Vol. 152 (june 2023) , p. 997-1009.e11
|
|
|
5.
|
|
14 p, 2.1 MB |
A Protein Misfolding Shaking Amplification-based method for the spontaneous generation of hundreds of bona fide prions
/
Eraña, Hasier (ATLAS Molecular Pharma S. L) ;
Sampedro-Torres-Quevedo, Cristina (Basque Research and Technology Alliance) ;
Charco, Jorge M. (ATLAS Molecular Pharma S. L) ;
Díaz-Domínguez, Carlos M. (Instituto de Salut Carlos III. Centro de Investigación Biomédica en Red de Enfermedades infecciosas) ;
Peccati, Francesca (Basque Research and Technology Alliance) ;
San-Juan-Ansoleaga, Maitena (Basque Research and Technology Alliance) ;
Vidal Barba, Enric (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal) ;
Gonçalves-Anjo, Nuno (Basque Research and Technology Alliance) ;
Pérez-Castro, Miguel A. (Basque Research and Technology Alliance) ;
González-Miranda, Ezequiel (Basque Research and Technology Alliance) ;
Piñeiro, Patricia (Basque Research and Technology Alliance) ;
Fernández-Veiga, Leire (Basque Research and Technology Alliance) ;
Galarza-Ahumada, Josu (Basque Research and Technology Alliance) ;
Fernández-Muñoz, Eva (Basque Research and Technology Alliance) ;
Pérez de Nanclares, Guiomar (Hospital Universitario de Araba Molecular (Epi)Genetics Laboratory) ;
Telling, Glenn (Colorado State University. Prion Research Center) ;
Geijo, Maria V (NEIKER-Basque Institute for Agricultural Research and Development) ;
Jiménez-Osés, Gonzalo (Basque Foundation for Science) ;
Castilla, Joaquín (Basque Foundation for Science)
Prion diseases are a group of rapidly progressing neurodegenerative disorders caused by the misfolding of the endogenous prion protein (PrP C) into a pathogenic form (PrP Sc). This process, despite being the central event underlying these disorders, remains largely unknown at a molecular level, precluding the prediction of new potential outbreaks or interspecies transmission incidents. [...]
2024 - 10.1038/s41467-024-46360-2
Nature communications, Vol. 15 (march 2024)
|
|
|
6.
|
|
13 p, 4.8 MB |
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
/
Mateo, Francesca (Institut d'Investigació Biomèdica de Bellvitge) ;
Arenas, E.J. (Institut de Recerca Biomèdica) ;
Aguilar, Helena (Institut d'Investigació Biomèdica de Bellvitge) ;
Serra-Musach, Jordi (Institut d'Investigació Biomèdica de Bellvitge) ;
Ruiz de Garibay, Gorka (Institut d'Investigació Biomèdica de Bellvitge) ;
Boni, Jacopo (Institut d'Investigació Biomèdica de Bellvitge) ;
Maicas, M. (Universidad de Navarra) ;
Du, S. (New York University School of Medicine) ;
Iorio, F. (Wellcome Trust Sanger Institute) ;
Herranz-Ors, Carmen (Institut d'Investigació Biomèdica de Bellvitge) ;
Islam, A. (University of Dhaka) ;
Prado, X. (Institut d'Investigació Biomèdica de Bellvitge) ;
Llorente, A. (Institut d'Investigació Biomèdica de Bellvitge) ;
Petit Montserrat, Anna (Hospital Universitari de Bellvitge) ;
Vidal, August (Hospital Universitari de Bellvitge) ;
Català, Isabel (Hospital Universitari de Bellvitge) ;
Soler, Teresa (Hospital Universitari de Bellvitge) ;
Venturas, G. (Hospital Universitari de Bellvitge) ;
Rojo-Sebastian, A. (MD Anderson Cancer Center) ;
Serra, H. (Institut d'Investigació Biomèdica de Bellvitge) ;
Cuadras, Daniel (Institut d'Investigació Biomèdica de Bellvitge) ;
Blanco, I. (Institut d'Investigació Biomèdica de Bellvitge) ;
Lozano, J. (Hospital Universitario Virgen de la Victoria) ;
Canals, Francesc (Hospital Universitari Vall d'Hebron) ;
Sieuwerts, A.M. (Cancer Genomics Centre) ;
De Weerd, V. (Cancer Genomics Centre) ;
Look, M.P. (Cancer Genomics Centre) ;
Puertas, Sara (Institut d'Investigació Biomèdica de Bellvitge) ;
García, N. (Institut d'Investigació Biomèdica de Bellvitge) ;
Perkins, A.S. (University of Rochester Medical Center) ;
Bonifaci, Nuria (Institut d'Investigació Biomèdica de Bellvitge) ;
Skowron, M. (Institut d'Investigació Biomèdica de Bellvitge) ;
Gómez-Baldó, Laia (Institut d'Investigació Biomèdica de Bellvitge) ;
Hernández, V. (Institut d'Investigació Biomèdica de Bellvitge) ;
Martínez-Aranda, Antonio (Institut d'Investigació Biomèdica de Bellvitge) ;
Martínez-Iniesta, Maria (Institut d'Investigació Biomèdica de Bellvitge) ;
Serrat Farran, Xènia (Institut d'Investigació Biomèdica de Bellvitge) ;
Cerón, Julián (Institut d'Investigació Biomèdica de Bellvitge) ;
Brunet, J. (Institut d'Investigació Biomèdica de Girona) ;
Barretina, M.P. (Institut d'Investigació Biomèdica de Girona) ;
Gil, Mercedes (Institut d'Investigació Biomèdica de Bellvitge) ;
Falo, Catalina (Institut d'Investigació Biomèdica de Bellvitge) ;
Fernández, A. (Institut d'Investigació Biomèdica de Bellvitge) ;
Morilla, I. (Institut d'Investigació Biomèdica de Bellvitge) ;
Pernas, Sonia (Institut d'Investigació Biomèdica de Bellvitge) ;
Plà, M.J. (Hospital Universitari de Bellvitge) ;
Andreu, Xavier (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Segui Palmer, Miquel Angel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Ballester, Rosa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Castellà Fernández, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Nellist, M. (Erasmus Medical Centre) ;
Morales, S. (Hospital Universitari Arnau de Vilanova) ;
Valls, J. (Hospital Universitari Arnau de Vilanova) ;
Velasco, A. (Hospital Universitari Arnau de Vilanova) ;
Matias-Guiu, X. (Hospital Universitari Arnau de Vilanova) ;
Figueras, Agnes (Institut d'Investigació Biomèdica de Bellvitge) ;
Sánchez-Mut, José Vicente (Institut d'Investigació Biomèdica de Bellvitge) ;
Sanchez-Cespedes, Montse (Institut d'Investigació Biomèdica de Bellvitge) ;
Cordero Casanovas, Alex (Institut d'Investigació Biomèdica de Bellvitge) ;
Gómez-Miragaya, Jorge (Institut d'Investigació Biomèdica de Bellvitge) ;
Palomero, Luis (Institut d'Investigació Biomèdica de Bellvitge) ;
Gómez, A. (Institut d'Investigació Biomèdica de Bellvitge) ;
Gajewski, T.F. (University of Chicago) ;
Cohen, E.E.W. (University of California San Diego) ;
Jesiotr, M. (Military Institute of Medicine) ;
Bodnar, L. (Military Institute of Medicine) ;
Quintela-Fandino, M. (Centro Nacional de Investigaciones Oncológicas) ;
López-Bigas, N. (Institució Catalana de Recerca i Estudis Avançats) ;
Valdés-Mas, R. (Universidad de Oviedo) ;
Puente, X.S. (Universidad de Oviedo) ;
Viñals, Francesc (Institut d'Investigació Biomèdica de Bellvitge) ;
Casanovas, O. (Institut d'Investigació Biomèdica de Bellvitge) ;
Graupera, M. (Institut d'Investigació Biomèdica de Bellvitge) ;
Hernandez-Losa, Javier (Hospital Universitari Vall d'Hebron) ;
Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron) ;
García-Alonso, L. (European Molecular Biology Laboratory-European Bioinformatics Institute) ;
Saez-Rodriguez, J. (European Molecular Biology Laboratory-European Bioinformatics Institute) ;
Esteller, M. (Universitat de Barcelona) ;
Sierra, A. (Universitat de Vic - Universitat Central de Catalunya) ;
Martín-Martín, N. (Center for Cooperative Research in Biosciences) ;
Matheu, A. (Ikerbasque. Basque Foundation for Science) ;
Carracedo, A. (Universidad del País Vasco) ;
González-Suárez, Eva (Institut d'Investigació Biomèdica de Bellvitge) ;
Nanjundan, M. (University of South Florida) ;
Cortés, Javier (Hospital Universitari Vall d'Hebron) ;
Lazaro Garcia, Conxi (Institut d'Investigació Biomèdica de Bellvitge) ;
Odero, M.D. (Universidad de Navarra) ;
Martens, J.W.M. (Cancer Genomics Centre) ;
Moreno-Bueno, G. (Universidad Autónoma de Madrid) ;
Barcellos-Hoff, M.H. (New York University School of Medicine) ;
Villanueva, Alberto (Institut d'Investigació Biomèdica de Bellvitge) ;
Gomis, R.R. (Institució Catalana de Recerca i Estudis Avançats) ;
Genestar Pujana, Miguel Ángel (Institut d'Investigació Biomèdica de Bellvitge) ;
Universitat Autònoma de Barcelona
Inhibitors of the mechanistic target of rapamycin (mTOR) are currently used to treat advanced metastatic breast cancer. However, whether an aggressive phenotype is sustained through adaptation or resistance to mTOR inhibition remains unknown. [...]
2017 - 10.1038/onc.2016.427
Oncogene, Vol. 36 Núm. 19 (november 2017) , p. 2737-2749
|
|
|
7.
|
|
12 p, 333.4 KB |
Detailed comparison between organic and conventional milk from Holstein-Friesian dairy herds in Italy
/
Manuelian, Carmen L (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ;
Vigolo, V. (Università degli Studi di Padova) ;
Burbi, S. (Coventry University) ;
Righi, F. (Università degli Studi di Parma) ;
Simoni, M. (Università degli Studi di Parma) ;
De Marchi, M. (Università degli Studi di Padova)
Several studies have reported gross composition differences between organic and conventional milk; however, most studies have not considered other factors such as breed and diet ingredients, which are known to influence milk composition. [...]
2022 - 10.3168/jds.2021-21465
Journal of dairy science, Vol. 105 Núm. 7 (2022) , p. 5561-5572
|
|
|
8.
|
|
8 p, 1.3 MB |
The Role of Digital Rectal Examination Prostate Volume Category in the Early Detection of Prostate Cancer : Its Correlation with the Magnetic Resonance Imaging Prostate Volume
/
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Picola, Natàlia (Hospital Universitari de Bellvitge) ;
Muñoz-Rodríguez, Jesús (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Paesano, Nahuel (Clinica Creu Blanca) ;
Ruiz-Plazas, Xavier (Hospital Universitari Joan XXIII de Tarragona) ;
Muñoz-Rivero, Marta V. (Hospital Universitari Arnau de Vilanova) ;
Celma, Ana (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
García-de Manuel, Gemma (Hospital Universitari de Girona Doctor Josep Trueta) ;
Miró, Berta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ;
Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
To relate the prostate volume category (PVC) assessed with digital rectal examination (DRE)-small, median, and large-and the prostate volumes (PVs) assessed with magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS). [...]
2024 - 10.5534/wjmh.230028
The world journal of men's health, Vol. 42 (january 2024) , p. 441-448
|
|
|
9.
|
|
11 p, 824.6 KB |
Cost-Utility of Attachment-Based Compassion Therapy (ABCT) and Mindfulness-Based Stress Reduction (MBSR) in the Management of Depressive, Anxious, and Adjustment Disorders in Mental Health Settings : Economic Evaluation Alongside a Randomized Controlled Trial
/
D'Amico, Francesco (London School of Economics and Political Science) ;
Montero-Marín, Jesús (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Cardeñosa, Eugenia (CUAP Pura Fernández) ;
Navarro-Gil, Mayte (Universidad de Zaragoza) ;
Pérez-Aranda, Adrián (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
López-del-Hoyo, Yolanda (Universidad de Zaragoza) ;
Collado-Navarro, Carlos (Universidad de Zaragoza) ;
Garcia-Campayo, Javier (Universidad de Zaragoza) ;
Luciano, Juan V (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Navarrete Hidalgo, Jaime (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública)
Objectives: The main objective of this paper was to examine the cost-utility of attachment-based compassion therapy (ABCT) compared to Mindfulness-Based Stress Reduction (MBSR) and treatment-as-usual (TAU) on patients with depressive and/or anxious disorder, or adjustment disorder with depressive and/or anxious symptomatology in terms of effects on quality-adjusted life years (QALYs) as well as healthcare costs from a public healthcare system perspective. [...]
2024 - 10.1007/s12671-024-02319-4
Mindfulness, Vol. 15 Núm. 3 (2024) , p. 559-569
|
|
|
10.
|
|
19 p, 1.5 MB |
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
/
Wieduwilt, M.J. (University of Oklahoma) ;
Metheny, L. (University Hospitals Seidman Cancer Center) ;
Zhang, M.J. (Medical College of Wisconsin) ;
Wang, H.L. (Center for International Blood and Marrow Transplant Research) ;
Estrada-Merly, N. (Center for International Blood and Marrow Transplant Research) ;
Marks, D.I. (University Hospitals Bristol National Health Service Trust) ;
Samer Al-Homsi, A. (New York University Langone Health) ;
Muffly, L. (Stanford University) ;
Chao, N. (Duke University Medical Center) ;
Rizzieri, D. (Duke University) ;
Gale, R.P. (Imperial College London) ;
Gadalla, S.M. (National Institutes of Health) ;
Cairo, M. (New York Medical College) ;
Mussetti, Alberto (Institut d'Investigació Biomèdica de Bellvitge) ;
Gore, S. (Yale New Haven Hospital) ;
Bhatt, V.R. (University of Nebraska Medical Center) ;
Patel, S.S. (University of Utah) ;
Michelis, F.V. (Princess Margaret Cancer Centre) ;
Inamoto, Y. (National Cancer Center Hospital) ;
Badawy, S.M. (Northwestern University Feinberg School of Medicine) ;
Copelan, E. (Atrium Health) ;
Palmisiano, N. (Thomas Jefferson University) ;
Kharfan-Dabaja, M.A. (Mayo Clinic) ;
Lazarus, H.M. (Case Western Reserve University) ;
Ganguly, S. (University of Kansas Health System) ;
Bredeson, C. (The Ottawa Hospital Transplant and Cellular Therapy Program) ;
Perez, M.A.D. (Hospital Infantil Universitario Niño Jesus) ;
Cassaday, R. (University of Washington) ;
Savani, B.N. (Vanderbilt University Medical Center) ;
Ballen, K. (Division of Hematology/Oncology. University of Virginia Health System) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Wirk, B. (Penn State Cancer Institute) ;
Bacher, U. (University of Bern) ;
Aljurf, Mahmoud (King Faisal Specialist Hospital Center and Research) ;
Bashey, A. (Northside Hospital) ;
Murthy, H.S. (Mayo Clinic) ;
Yared, J.A. (University of Maryland) ;
Aldoss, I. (City of Hope Medical Center) ;
Farhadfar, N. (University of Florida College of Medicine) ;
Liu, H. (University of Chicago Medicine) ;
Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ;
Waller, E.K. (Emory University) ;
Solh, M. (Northside Hospital) ;
Seftel, M.D. (University of British Columbia) ;
van der Poel, M. (Maastricht University Medical Center) ;
Grunwald, M.R. (Atrium Health) ;
Liesveld, J.L. (University of Rochester Medical Center) ;
Kamble, R.T. (Baylor College of Medicine) ;
McGuirk, J. (University of Kansas Health System) ;
Munker, R. (University of Kentucky) ;
Cahn, Jean-Yves (Universite Grenoble Alpes) ;
Lee, J.W. (The Catholic University of Korea) ;
Freytes, C.O. (University of Texas Health Science Center) ;
Krem, M.M. (University of Kentucky) ;
Winestone, L.E. (University of California) ;
Gergis, U. (Thomas Jefferson University) ;
Nathan, S. (Rush University Medical Center) ;
Olsson, R.F. ($u Karolinska Institutet (Estocolm, Suècia)) ;
Verdonck, L.F. (Isala Clinic) ;
Sharma, A. (St. Jude Children's Research Hospital) ;
Ringden, O. ($u Karolinska Institutet (Estocolm, Suècia)) ;
Friend, B.D. (Baylor College of Medicine) ;
Cerny, J. (University of Massachusetts Medical Center) ;
Choe, H. (The Ohio State University Wexner Medical Center) ;
Chhabra, S. (Center for International Blood and Marrow Transplant Research) ;
Nishihori, T. (Moffitt Cancer Center) ;
Seo, S. (Dokkyo Medical University) ;
George, B. (Christian Medical College) ;
Baxter-Lowe, L.A. (Children's Hospital Los Angeles) ;
Hildebrandt, G.C. (University of Kentucky) ;
de Lima, M. (University Hospitals Case Medical Center) ;
Litzow, M. (Mayo Clinic Rochester) ;
Kebriaei, P. (The University of Texas MD Anderson Cancer Center) ;
Hourigan, C.S. (National Institutes of Health) ;
Abid, M.B. (Medical College of Wisconsin) ;
Weisdorf, D.J. (University of Minnesota) ;
Saber, W. (Center for International Blood and Marrow Transplant Research) ;
Universitat Autònoma de Barcelona
The role of haploidentical hematopoietic cell transplantation (HCT) using posttransplant cyclophosphamide (PTCy) for acute lymphoblastic leukemia (ALL) is being defined. We performed a retrospective, multivariable analysis comparing outcomes of HCT approaches by donor for adults with ALL in remission. [...]
2022 - 10.1182/bloodadvances.2021004916
Blood advances, Vol. 6 Núm. 1 (november 2022) , p. 339-357
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
